SARS-CoV-2 Variants and Vaccination
Author(s) -
Yang Liu,
Jianying Liu,
PeiYong Shi
Publication year - 2022
Publication title -
zoonoses
Language(s) - English
Resource type - Journals
eISSN - 2737-7474
pISSN - 2737-7466
DOI - 10.15212/zoonoses-2022-0001
Subject(s) - virology , transmission (telecommunications) , evasion (ethics) , coronavirus , vaccination , immunity , biology , disease , covid-19 , viral replication , virus , immune system , immunology , medicine , infectious disease (medical specialty) , pathology , electrical engineering , engineering
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused global destruction since its emergence in late 2019. Over the past 2 years, the virus has continually evolved in human hosts, thus leading to the emergence of variants with altered viral transmission, disease severity, and evasion of immunity. Although vaccines for coronavirus disease 2019 (COVID-19) have been developed at an unprecedented pace, the emergence of variants has posed a constant threat to the effectiveness of the approved vaccines. In this Commentary, we review the key variants and discuss their implications in viral replication, transmission, and immune evasion.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom